UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

~~Pursuant~~PURSUANT toTO ~~Section~~SECTION 13 orOR ~~Section~~ 15(d)

ofOF ~~the~~THE ~~Securities~~SECURITIES ~~Exchange~~EXCHANGE ~~Act~~ACT ofOF 1934

Date of Report (Date of earliest event reported): ~~April 11~~November 28, 2022

REVOLUTION HEALTHCARE ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

Delaware	001-40190	86-1403778
(State or other jurisdiction of incorporation or organization)	(Commission File Number)	(I.R.S. Employer Identification Number)
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

20 University Road Cambridge, Massachusetts		02138
20 University Road, Cambridge, Massachusetts		02138
(Address of principal executive offices)		(Zip Code)

(617) 234-7000

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K ~~filing~~ is intended to simultaneously satisfy the filing obligation toof the registrant under any of the following provisions:

☐ Written ~~communications~~communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐☒ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-~~commencement~~commencements communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading ~~Symbol(s)~~Symbols	Name of each exchange on which registered
SAILSM (Stakeholder Aligned Initial Listing) securities, each consisting of one share of Class A common Stock, $0.0001 par value, and one-fifth of one redeemable warrant to acquire one share of Class A Common Stock	REVHU	The ~~NASDAQ~~Nasdaq Stock Market LLC
Class A Common Stock included as part of the SAILSM securities	REVH	The ~~NASDAQ~~Nasdaq Stock Market LLC
Redeemable Warrants included as part of the SAILSM securities, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50	REVHW	The ~~NASDAQ~~Nasdaq Stock Market LLC

☒

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 5 8.0201. ~~Departure~~Other ~~of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers~~Events.

On ~~April 11~~November 28, 2022, ~~Robert~~Revolution ~~Nelsen~~Healthcare ~~and~~Acquisition ~~Hemant~~Corp. ~~Taneja~~(the ~~resigned~~“Company”) issued a press release announcing that will redeem all of its outstanding shares of Class A Common Stock, par value $0.0001, issued by the Company in its initial public offering, effective as ~~members~~of the close of business on December 2, 2022, if at the ~~Board~~Company’s Special Meeting on December 2, 2022, the requisite stockholders of ~~Directors~~the (Company approve the ~~“Board”)~~proposed amendment to the Company’s Amended and Restated Certificate of ~~Revolution~~Incorporation ~~Healthcare~~and ~~Acquisition~~the ~~Corp.~~proposed (amendment to that certain Investment Management Trust Agreement, dated March 17, 2021, by and between the “Company”) ~~effective~~and ~~immediately~~Continental Stock Transfer & Trust Company, a New York limited purpose trust company, as trustee, in each case, as described in the definitive proxy statement filed by the Company with the Securities and Exchange Commission on November 7, 2022, as may be amended or supplemented from time to time.

~~Mr.~~Item ~~Nelsen’s and Mr~~9. ~~Taneja’s resignations did not result from any disagreements with the Company on any matter relating to its operations, policies, or practices~~01. ~~The~~Financial ~~size~~Statements ~~of the Board is now five following Mr. Nelsen’s~~ and MrExhibits. ~~Taneja’s departures. Following their resignation from the Board, Mr. Nelsen and Mr. Taneja shall serve as observers to the Board.~~


Exhibit No.		Description

99.1		Press Release, dated November 28, 2022

104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: ~~April 11~~November 28, 2022

~~REVOLUTION~~Revolution ~~HEALTHCARE~~Healthcare ~~ACQUISITION~~Acquisition ~~CORP~~Corp. By: /s/ Mark McDonnell Name: Mark McDonnell Title: Chief Financial Officer

Filing Compare · Revolution Healthcare Acquisition Corp.